Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.

Yeming WangFei ZhouDingyu ZhangJianping ZhaoRonghui DuYi HuZhenshun ChengLing GaoYang JinGuangwei LuoShouzhi FuQiaofa LuGuanhua DuKe WangYang LuGuohui FanYi ZhangYing LiuShunan RuanWen LiuThomas JakiFrederick G HaydenPeter W HorbyBin CaoChen Wang

Published in: Trials (2020)

ClinicalTrials.gov: NCT04257656. Registered on 6 February 2020.

Keyphrases

double blind
placebo controlled
phase iii
phase ii
study protocol
clinical trial
coronavirus disease
sars cov
phase ii study
high dose
early onset
randomized controlled trial
respiratory syndrome coronavirus
squamous cell carcinoma